These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
309 related items for PubMed ID: 27990607
21. Venous thromboembolism does not share familial susceptibility with retinal vascular occlusion or glaucoma: a nationwide family study. Zöller B, Li X, Sundquist J, Sundquist K. J Thromb Thrombolysis; 2016 Nov; 42(4):505-12. PubMed ID: 27283943 [Abstract] [Full Text] [Related]
22. Risk of venous thromboembolism in men with prostate cancer compared with men in the general population: a nationwide population-based cohort study in Sweden. Balabanova Y, Farahmand B, Garmo H, Stattin P, Brobert G. BMJ Open; 2022 May 23; 12(5):e055485. PubMed ID: 35606159 [Abstract] [Full Text] [Related]
25. Atrial fibrillation associated with increased risk of venous thromboembolism. A population-based cohort study. Wang CC, Lin CL, Wang GJ, Chang CT, Sung FC, Kao CH. Thromb Haemost; 2015 Jan 23; 113(1):185-92. PubMed ID: 25318828 [Abstract] [Full Text] [Related]
28. A Validated Risk Score for Venous Thromboembolism Is Predictive of Cancer Progression and Mortality. Kuderer NM, Culakova E, Lyman GH, Francis C, Falanga A, Khorana AA. Oncologist; 2016 Jul 23; 21(7):861-7. PubMed ID: 27125754 [Abstract] [Full Text] [Related]
29. Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort study. Brand JS, Hedayati E, Bhoo-Pathy N, Bergh J, Hall P, Humphreys K, Ludvigsson JF, Czene K. Cancer; 2017 Feb 01; 123(3):468-475. PubMed ID: 27727456 [Abstract] [Full Text] [Related]
30. Red cell distribution width is associated with incident venous thromboembolism (VTE) and case-fatality after VTE in a general population. Ellingsen TS, Lappegård J, Skjelbakken T, Brækkan SK, Hansen JB. Thromb Haemost; 2015 Jan 01; 113(1):193-200. PubMed ID: 25274492 [Abstract] [Full Text] [Related]
37. Association Between Decreased Serum Albumin With Risk of Venous Thromboembolism and Mortality in Cancer Patients. Königsbrügge O, Posch F, Riedl J, Reitter EM, Zielinski C, Pabinger I, Ay C. Oncologist; 2016 Feb 27; 21(2):252-7. PubMed ID: 26764252 [Abstract] [Full Text] [Related]
38. Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events. Chang WT, Chang CL, Ho CH, Hong CS, Wang JJ, Chen ZC. J Am Heart Assoc; 2017 May 03; 6(5):. PubMed ID: 28468786 [Abstract] [Full Text] [Related]
39. Impact of time since diagnosis and mortality rate on cancer-associated venous thromboembolism: the Scandinavian Thrombosis and Cancer (STAC) cohort. Blix K, Gran OV, Severinsen MT, Cannegieter SC, Jensvoll H, Overvad K, Hammerstrøm J, Tjønneland A, Naess IA, Braekkan SK, Rosendaal FR, Kristensen SR, Hansen JB. J Thromb Haemost; 2018 Jul 03; 16(7):1327-1335. PubMed ID: 29691978 [Abstract] [Full Text] [Related]
40. Age-and sex-specific seasonal variation of venous thromboembolism in patients with and without family history: a nationwide family study in Sweden. Zöller B, Li X, Ohlsson H, Sundquist J, Sundquist K. Thromb Haemost; 2013 Dec 03; 110(6):1164-71. PubMed ID: 24048360 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]